Paper34768751
Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives.
Dehshahri A and 8 others. Int J Mol Sci, 2021. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives. Papers, record 34768751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34768751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Editing | Major topic |
| SOX Transcription Factors | Major topic |
| Animals | |
| CRISPR-Cas Systems | |
| Clustered Regularly Interspaced Short Palindromic Repeats | |
| Genetic Engineering | |
| Genome | |
| Humans | |
| Neoplasms | |
| Stem Cells |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MOE-T2EP30120-0016 | Ministry of Education | PubMed |
Source PubMed
References150
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25209882 | Conjugation of poly(amidoamine) dendrimers with various acrylates for improved delivery of plasmid encoding interleukin-12 gene. | J Biomater Appl | 2015 | https://conductscience.org/library/papers/25209882 | PubMed |
| 2 | 30356064 | SOX17 regulates uterine epithelial-stromal cross-talk acting via a distal enhancer upstream of Ihh. | Nat Commun | 2018 | https://conductscience.org/library/papers/30356064 | PubMed |
| 3 | 22363260 | Role of transcription factors in peripheral nerve regeneration. | Front Mol Neurosci | 2012 | https://conductscience.org/library/papers/22363260 | PubMed |
| 4 | 34403806 | CRISPR/Cas9-mediated gene editing on Sox2ot promoter leads to its truncated expression and does not influence neural tube closure and embryonic development in mice. | Biochem Biophys Res Commun | 2021 | https://conductscience.org/library/papers/34403806 | PubMed |
| 5 | 32008085 | EMT signaling: potential contribution of CRISPR/Cas gene editing. | Cell Mol Life Sci | 2020 | https://conductscience.org/library/papers/32008085 | PubMed |
| 6 | 17055661 | SRY-box containing gene 11 (Sox11) transcription factor is required for neuron survival and neurite growth. | Neuroscience | 2006 | https://conductscience.org/library/papers/17055661 | PubMed |
| 7 | 29717202 | Double domain polyethylenimine-based nanoparticles for integrin receptor mediated delivery of plasmid DNA. | Sci Rep | 2018 | https://conductscience.org/library/papers/29717202 | PubMed |
| 8 | 26384302 | Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma. | Oncotarget | 2015 | https://conductscience.org/library/papers/26384302 | PubMed |
| 9 | 25512558 | A Sox2 distal enhancer cluster regulates embryonic stem cell differentiation potential. | Genes Dev | 2014 | https://conductscience.org/library/papers/25512558 | PubMed |
| 10 | 30607331 | The Impact of CRISPR-Cas System on Antiviral Therapy. | Adv Pharm Bull | 2018 | https://conductscience.org/library/papers/30607331 | PubMed |
| 11 | 29132362 | Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122. | Mol Cancer | 2017 | https://conductscience.org/library/papers/29132362 | PubMed |
| 12 | 34269521 | Controlled CRISPR-Cas9 Ribonucleoprotein Delivery for Sensitized Photothermal Therapy. | Small | 2021 | https://conductscience.org/library/papers/34269521 | PubMed |
| 13 | 31189761 | Generation of bicistronic reporter knockin mice for visualizing germ layers. | Exp Anim | 2019 | https://conductscience.org/library/papers/31189761 | PubMed |
| 14 | 27840399 | The CRISPR Growth Spurt: from Bench to Clinic on Versatile Small RNAs. | J Microbiol Biotechnol | 2017 | https://conductscience.org/library/papers/27840399 | PubMed |
| 15 | 30405772 | The SOX2OT/miR-194-5p axis regulates cell proliferation and mobility of gastric cancer through suppressing epithelial-mesenchymal transition. | Oncol Lett | 2018 | https://conductscience.org/library/papers/30405772 | PubMed |
| 16 | 22992727 | Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22992727 | PubMed |
| 17 | 26422227 | Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. | Cell | 2015 | https://conductscience.org/library/papers/26422227 | PubMed |
| 18 | 33739574 | Sox2 controls neural stem cell self-renewal through a Fos-centered gene regulatory network. | Stem Cells | 2021 | https://conductscience.org/library/papers/33739574 | PubMed |
| 19 | 29189942 | The Conspicuity of CRISPR-Cpf1 System as a Significant Breakthrough in Genome Editing. | Curr Microbiol | 2018 | https://conductscience.org/library/papers/29189942 | PubMed |
| 20 | 16582099 | The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors. | Nucleic Acids Res | 2006 | https://conductscience.org/library/papers/16582099 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41268614 | Role of the SOX family in non‑small cell lung cancer: Molecular mechanisms and therapeutic implications (Review). | Oncol Rep | 2026 | https://conductscience.org/library/papers/41268614 | PubMed |
| 40392306 | The SOX gene superfamily in oncogenesis: unraveling links to ncRNAs, key pathways, chemoresistance, and gene editing approaches. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40392306 | PubMed |
| 39194140 | Novel approaches for HTLV-1 therapy: innovative applications of CRISPR-Cas9. | Rev Inst Med Trop Sao Paulo | 2024 | https://conductscience.org/library/papers/39194140 | PubMed |
| 38649821 | Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer. | BMC Mol Cell Biol | 2024 | https://conductscience.org/library/papers/38649821 | PubMed |
| 37998761 | gjSOX9 Cloning, Expression, and Comparison with gjSOXs Family Members in Gekko japonicus. | Curr Issues Mol Biol | 2023 | https://conductscience.org/library/papers/37998761 | PubMed |
| 36969044 | Editorial: CRISPR advancement in cancer research and future perspectives. | Front Oncol | 2023 | https://conductscience.org/library/papers/36969044 | PubMed |
Genes37
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34768751
GET https://conductscience.org/api/papers/v1/34768751/references?page=2